Johnson & Johnson (JNJ) begins on Tuesday its third attempt to push through a multi-billion-dollar settlement relating to claims its baby ...

Johnson & Johnson is facing a critical test over its $10B proposal to end litigation alleging that its baby powder caused ovarian cancer, as it tries to convince a judge to sign off on its third ...

Johnson & Johnson faces a critical test on Tuesday over its $10 billion proposal to end litigation alleging that its baby powder caused ovarian cancer, as it tries to convince a judge to sign off on ...

Household healthcare giant Johnson and Johnson is bracing for a crucial test that could conclude litigation linked to its baby powder, which was recalled following allegations of causing ovarian ...